VALIANTLAB

The stock has been placed in Enhanced Surveillance Measure (ESM) list ESM - II (35).

Valiant Laboratories Ltd.

NSE: VALIANTLAB

BSE: 543998

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

128.43-2.6 (-2.00%)

23 Oct, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

8.5 / 100

Value Score

20.4 / 100

Price Momentum Score

97.9 / 100

QVM Score

30.7 / 100

Key Metrics

Market Cap

697.54

P/E (TTM)

43.58

P/B

2.24

P/S (TTM)

2.28

EV/EBITDA

21.36

CAPE (5Y)

31.59

ROE (TTM)

-1.20

ROCE (TTM)

0.10

ROA (TTM)

-0.76

Avg 3Y ROE

-0.65

Earnings 3Y CAGR

-27.27

Sales 3Y CAGR

-10.74

Sales 5Y CAGR

Debt/Equity

0.15

Consensus TP

Strong Buy %

Promoter Holding

74.94

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Valiant Laboratories Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Strong price momentum

Price Momentum score of 97.9 indicates that the stock has strong price momentum. Research has shown that stocks with higher momentum continue to outperform in the near term

What is Price Momentum score?

97.9 / 100

Negative

Expensive and at a premium to industry median P/E

PE TTM of 43.58 indicates that the stock is expensive on a standalone basis and is at a 43.03% premium to industry median P/E

What is P/E Ratio?

Median: 30.47

Value 43.58

-0.82614.73

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Company's earnings are of moderate quality

Earnings quality score of 66.7 indicates that the company's earnings are of moderate quality. Earnings quality is measured using combination of earnings persistence, probability of manipulation and earnings to cash conversion

What is Earnings quality score?

66.7 / 100

Financial Snapshot

See detailed analysis

Multi-year trends for Valiant Laboratories Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Valiant Laboratories Ltd. Shareholding Pattern

Quarterly breakdown of Valiant Laboratories Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Total Promoter	74.94	74.94	74.94	74.94	74.94	74.94	74.94	74.94	74.94	74.94	74.94	74.94	74.94
Indian Promoter	74.94	74.94	74.94	74.94	74.94	74.94	74.94	74.94	74.94	74.94	74.94	74.94	74.94
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	10.40	7.51	3.48	1.89	0.00	0.00	0.64	0.63	0.02	0.01	0.20	0.00	0.15
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.04	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	8.64	7.08	3.48	1.89	0.00	0.00	0.64	0.63	0.02	0.01	0.20	0.00	0.07
Other Institutions	1.72	0.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.08
Non-Institution	14.66	17.55	21.58	23.17	25.06	25.06	24.42	24.43	25.04	25.05	24.86	25.06	24.91
Bodies Corporate	0.02	2.93	5.50	6.09	6.61	6.26	6.82	5.37	3.29	3.04	3.06	3.14	3.18
Others (incl. Retail) No. of shareholders	14.64 37,407	14.62 15,761	16.08 14,839	17.08 14,178	18.45 15,101	18.80 15,604	17.60 14,959	19.06 14,354	21.75 15,007	22.01 14,844	21.80 14,589	21.92 14,277	21.73 14,540

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Valiant Laboratories Ltd. shares as reported to NSE and BSE.

Name	Date	Type	Price	Qty.	Value
METASONI ALLOYS PVT LTD	17 Dec 2025	sell	₹ 66.98	7.74 k	₹ 5.19 lac
METASONI ALLOYS PVT LTD	17 Dec 2025	buy	₹ 67.33	3.12 lac	₹ 2.10 cr
TRADE CORNER	13 Jun 2025	sell	₹ 120.29	2.35 lac	₹ 2.83 cr
NECTA BLOOM VCC - NECTA BLOOM ONE	31 Jan 2025	buy	₹ 102.75	2.75 lac	₹ 2.83 cr
MARWADI CHANDARANA INTERMEDIARIES BROKERS PRIVATE LIMITED	31 Jan 2025	sell	₹ 102.75	2.75 lac	₹ 2.83 cr
MONEY LOGIX SECURITIES PVT LTD	24 Jan 2025	buy	₹ 105.78	5.50 lac	₹ 5.82 cr
JAINAM BROKING LIMITED	24 Jan 2025	sell	₹ 105.77	5.50 lac	₹ 5.82 cr
JALIYAN COMMODITY	07 Jun 2024	buy	₹ 142.81	3.49 lac	₹ 4.99 cr
JAINAM BROKING LIMITED	07 Jun 2024	sell	₹ 142.80	3.44 lac	₹ 4.92 cr
JAINAM BROKING LIMITED	07 Jun 2024	buy	₹ 148.54	12.30 k	₹ 18.27 lac

Corporate Actions

History of Valiant Laboratories Ltd. dividends, bonus issues, stock splits, rights issues, and other corporate events.

Rights Issue(1 new shares @ ₹75 for 4 existing shares)
Ex-date: 18th Jul 2025Announced on: 15th Jul 2025
"Rights ISIN INE0JWS20017CINS Y933BC122SEDOL BV2CZY9."

Company Profile

Overview of Valiant Laboratories Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Valiant Laboratories Limited is an India-based pharmaceutical ingredient manufacturing company. The Company is focused on manufacturing a Paracetamol active pharmaceutical ingredient (API)/bulk drug. It has several applications in the treatment of conditions such as headache, muscle ache, arthritis,...

Key personnel

Mr. Akshay Dnyaneshwar Gangurde

Compliance Officer, Company Secretary

Mr. Bhupendra Manohar Raul

Quality Assurance Manager

Mr. Jyotibhushan Singh

Head - Unit

Mr. Mulesh Manilal SavlaD

Non-Executive Independent Chairman of the Board

Mr. Paresh Shashikant ShahD

Chief Financial Officer, Whole-Time Director

Shri. Santosh Shantilal VoraD

Managing Director, Executive Director

Mr. Sandeep GuptaD

Non-Executive Director

Mr. Shantilal Shivji VoraD

Non-Executive Director

View all

Incorporated on

16 Aug 2021

Last Annual

31 Mar 2026

Last Interim

30 Jun 2026

No. of Employees

IPO date

06 Oct 2023

Free Float

1,26,11,013

Website

https://valiantlabs.in/

Phone no.

+91249712001

Address

104, 1st Floor, Udyog Kshetra, Above Krishna Motors, Near D-mart, Mulund Goregaon Link Road, Mulund (West), MUMBAI, 400080, India

Frequently Asked Questions

What is the current share price of Valiant Laboratories Ltd.?

The current share price of Valiant Laboratories Ltd. is ₹ 128.43 as of 23 Oct 2026.

What is the market capitalisation of Valiant Laboratories Ltd.?

The market capitalisation of Valiant Laboratories Ltd. stands at ₹ 697.54 Cr.

What is the PE ratio of Valiant Laboratories Ltd.?

The Price-to-Earnings (PE) ratio of Valiant Laboratories Ltd. is 43.58 as of the latest trailing twelve months data.

What is the ROE and ROCE of Valiant Laboratories Ltd.?

Valiant Laboratories Ltd. has a Return on Equity (ROE) of -1.20% and a Return on Capital Employed (ROCE) of 0.10% as per the latest financial reports.

What is the 52-week high and low of Valiant Laboratories Ltd.?

The 52-week high of Valiant Laboratories Ltd. is - and the 52-week low is -.

What is the dividend yield of Valiant Laboratories Ltd.?

The dividend yield of Valiant Laboratories Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Valiant Laboratories Ltd.?

Foreign Institutional Investors (FII) hold 0.07%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 21.73% of Valiant Laboratories Ltd. shares.

What sector does Valiant Laboratories Ltd. belong to?

Valiant Laboratories Ltd. operates in the Healthcare sector.

What is the beta of Valiant Laboratories Ltd.?

The beta of Valiant Laboratories Ltd. is 0.99, indicating its price volatility relative to the broader market. Over the past 1 year, Valiant Laboratories Ltd. has delivered an absolute return of 54.21%.

What is the RSI of Valiant Laboratories Ltd.?

The 14-day Relative Strength Index (RSI) of Valiant Laboratories Ltd. is 55.73, placing it in the neutral zone. An RSI above 70 is considered overbought and below 30 is considered oversold.